ITCI Annual Operating Expenses
$587.81 M
+$95.50 M+19.40%
31 December 2023
Summary:
As of January 21, 2025, ITCI annual total operating expenses is $587.81 million, with the most recent change of +$95.50 million (+19.40%) on December 31, 2023. During the last 3 years, it has risen by +$335.95 million (+133.38%). ITCI annual operating expenses is now at all-time high.ITCI Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Quarterly Operating Expenses
$198.70 M
+$21.06 M+11.85%
30 September 2024
Summary:
As of January 21, 2025, ITCI quarterly total operating expenses is $198.70 million, with the most recent change of +$21.06 million (+11.85%) on September 30, 2024. Over the past year, it has increased by +$52.31 million (+35.73%). ITCI quarterly operating expenses is now at all-time high.ITCI Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.4% | +35.7% |
| 3 y3 years | +133.4% | +35.7% |
| 5 y5 years | +262.3% | +35.7% |
ITCI Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +63.6% | at high | +90.6% |
| 5 y | 5-year | at high | +281.7% | at high | +375.7% |
| alltime | all time | at high | +2911.1% | at high | >+9999.0% |
Intra-Cellular Therapies Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $198.70 M(+11.9%) |
| June 2024 | - | $177.65 M(+14.0%) |
| Mar 2024 | - | $155.90 M(+0.6%) |
| Dec 2023 | $587.81 M(+19.4%) | $154.90 M(+5.8%) |
| Sept 2023 | - | $146.39 M(-2.5%) |
| June 2023 | - | $150.14 M(+10.1%) |
| Mar 2023 | - | $136.37 M(+6.5%) |
| Dec 2022 | $492.31 M(+37.0%) | $128.06 M(+5.3%) |
| Sept 2022 | - | $121.65 M(-12.1%) |
| June 2022 | - | $138.35 M(+32.7%) |
| Mar 2022 | - | $104.26 M(-4.3%) |
| Dec 2021 | $359.36 M(+42.7%) | $108.98 M(+12.4%) |
| Sept 2021 | - | $96.93 M(+12.6%) |
| June 2021 | - | $86.11 M(+27.9%) |
| Mar 2021 | - | $67.34 M(-7.2%) |
| Dec 2020 | $251.86 M(+63.5%) | $72.60 M(+15.7%) |
| Sept 2020 | - | $62.75 M(-5.8%) |
| June 2020 | - | $66.62 M(+33.5%) |
| Mar 2020 | - | $49.90 M(+19.5%) |
| Dec 2019 | $154.01 M(-5.1%) | $41.77 M(+14.8%) |
| Sept 2019 | - | $36.38 M(-7.1%) |
| June 2019 | - | $39.17 M(+6.7%) |
| Mar 2019 | - | $36.70 M(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $162.27 M(+57.8%) | $42.62 M(-1.8%) |
| Sept 2018 | - | $43.39 M(+10.8%) |
| June 2018 | - | $39.17 M(+5.6%) |
| Mar 2018 | - | $37.08 M(+14.2%) |
| Dec 2017 | $102.84 M(-13.3%) | $32.47 M(+36.5%) |
| Sept 2017 | - | $23.79 M(+27.0%) |
| June 2017 | - | $18.73 M(-32.7%) |
| Mar 2017 | - | $27.85 M(-1.0%) |
| Dec 2016 | $118.59 M(+12.0%) | $28.13 M(-6.8%) |
| Sept 2016 | - | $30.19 M(-5.0%) |
| June 2016 | - | $31.77 M(+11.5%) |
| Mar 2016 | - | $28.50 M(-2.9%) |
| Dec 2015 | $105.84 M(+235.6%) | $29.34 M(-9.3%) |
| Sept 2015 | - | $32.35 M(+48.7%) |
| June 2015 | - | $21.75 M(-2.9%) |
| Mar 2015 | - | $22.40 M(+46.1%) |
| Dec 2014 | $31.53 M(+8.7%) | $15.33 M(+131.3%) |
| Sept 2014 | - | $6.63 M(+37.2%) |
| June 2014 | - | $4.83 M(+1.9%) |
| Mar 2014 | - | $4.74 M(-46.5%) |
| Dec 2013 | $29.00 M(+48.6%) | $8.86 M(+62.5%) |
| Sept 2013 | - | $5.45 M(>+9900.0%) |
| June 2013 | - | $10.80 K |
| Dec 2012 | $19.52 M | - |
FAQ
- What is Intra-Cellular Therapies annual total operating expenses?
- What is the all time high annual operating expenses for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual operating expenses year-on-year change?
- What is Intra-Cellular Therapies quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly operating expenses year-on-year change?
What is Intra-Cellular Therapies annual total operating expenses?
The current annual operating expenses of ITCI is $587.81 M
What is the all time high annual operating expenses for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual total operating expenses is $587.81 M
What is Intra-Cellular Therapies annual operating expenses year-on-year change?
Over the past year, ITCI annual total operating expenses has changed by +$95.50 M (+19.40%)
What is Intra-Cellular Therapies quarterly total operating expenses?
The current quarterly operating expenses of ITCI is $198.70 M
What is the all time high quarterly operating expenses for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly total operating expenses is $198.70 M
What is Intra-Cellular Therapies quarterly operating expenses year-on-year change?
Over the past year, ITCI quarterly total operating expenses has changed by +$52.31 M (+35.73%)